InsiderTrades

Form 4 for IMVT Immunovant, Inc.

Accepted 2026-06-16 16:03:13 ET · period of report 2026-06-15 · accession 0001764013-26-000069 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DT 2026-06-16 16:03 2026-06-15 IMVT Pande Atul Dir M - OptEx $8.43 +1,500 118.2K +1% +$12.6K
DT 2026-06-16 16:03 2026-06-15 IMVT Pande Atul Dir S - Sale+OE $34.02 -1,500 116.7K -1% -$51.0K
DT 2026-06-16 16:03 2026-06-15 IMVT Pande Atul Dir M - OptEx $0.00 -1,500 69.7K -2% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-06-15 M A 1,500 $8.43 118,231 D — — (F1) Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on December 26, 2025.
2 Common Common Stock 2026-06-15 S D 1,500 $34.02 116,731 D — — (F1) Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on December 26, 2025.
3 Derivative Stock Option (right to buy) 2026-06-15 M D 1,500 $0.00 69,681 D $8.43 · — to 2029-11-19 1,500 Common Stock (F1) Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on December 26, 2025. (F2) Reflects an award of stock options to purchase Common Shares that is fully vested. (F3) The Form 4 filed on May 20, 2026 inadvertently disclosed the total of all remaining options held by the Reporting Person following the reported transaction in this specific option. This total correctly reflects only the remaining options for the specific option.